Loading...
Loading...
ICLR| Name | Value |
|---|---|
| Revenues | 2,030.0M |
| Cost of Revenue | 1,438.6M |
| Gross Profit | 591.4M |
| Operating Expense | 298.1M |
| Operating I/L | 285.4M |
| Other Income/Expense | -50.9M |
| Interest Income | 2.4M |
| Pretax | 234.6M |
| Income Tax Expense | 37.4M |
| Net Income/Loss | 197.1M |
ICON Public Limited Company is a clinical research organization that provides outsourced development and commercialization services globally. The company specializes in strategic development, management, and analysis of programs supporting various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include patient recruitment, data and technology solutions, medical imaging, laboratory services, project management, biostatistics, medical writing, pharmacovigilance, and regulatory consulting. ICON serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations.
